Japan lab unable to replicate 'stem cell' findings (Update)

Aug 27, 2014
A photo released by Japan's national institute Riken on January 28, 2014 shows what is meant to be Stimulus Triggered Acquisition of Pluripotency (STAP) cells. The research has now been called into question.

Researchers in Japan said Wednesday they have been unable to replicate experiments that were hailed earlier this year as a "game-changer" in the quest to grow transplant tissue, amid claims evidence was faked.

In a scandal that rocked Japan's scientific establishment, Riken—the research institute that sponsored the study—launched an independent experiment in April to verify research published by scientist Haruko Obokata and her colleagues earlier this year.

But the failure to replicate the experiment casts further doubt on the existence of stem cell-like cells, what the researchers called Stimulus-Triggered Acquisition of Pluripotency (STAP) cells.

"Researchers have conducted 22 experiments thus far, but we could not confirm the emergence of cells in the conditions described in (Obokata's) papers," Riken said in an interim report issued Wednesday.

Obokata since July has been trying in tandem with independent teams to reproduce her own results.

The researchers will continue their experiments under more diverse conditions while also considering data obtained by Obokata herself, Shinichi Aizawa, a special adviser at Riken, told a lengthy press conference.

Obokata was feted after unveiling findings that appeared to show a straightforward way to re-programme adult cells to become stem cells—precursors that are capable of developing into any other cell in the human body.

Haruko Obokata, 30, a female researcher of Japan's Riken Institute, pictured at a press conference in Osaka, western Japan on April 9, 2014

Identifying a readily manufacturable supply of stem cells could one day help meet a need for transplant tissues, or even whole organs, meaning that any advance in the field is met with excitement in the scientific community.

But suspicions began to emerge in the weeks and months after the research was published, building into one of the biggest controversies in scientific publishing for a decade.

Leading science journal Nature withdrew the flawed stem-cell study after Obokata agreed in June to retract the papers.

Nature said it would tighten procedures to vet future studies submitted for publication.

It said the decision was taken after mistakes were discovered in some data published in two papers, photograph captions were found to be misleading, and the work itself could not be repeated by other scientists.

Earlier this month Obokata's co-author, stemcell scientist Yoshiki Sasai, hanged himself, further shaking Japan's scientific establishment.

Yoshiki Sasai, supervisor of 30-year-old scientist Haruko Obokata of Riken Institute, answers questions during a press conference in Tokyo on April 16, 2014

Researchers have been trying to replicate results appearing to show that exposing ordinary cells to various stresses had made them pluripotent, or able to develop into any type of tissue.

Riken had planned to implant these cells into mouse embryos to test whether they really were pluripotent.

But the experiments have been fraught with difficulty from the outset, with researchers unable to reproduce such cells.

On Wednesday Riken also announced a shake-up of the Center for Developmental Biology where the scandal took place, adding it planned to cut about half of its 40 laboratories.

CDB currently has around 400 researchers.

Explore further: Japanese scientist to retract stem cell papers

add to favorites email to friend print save as pdf

Related Stories

Japan scientist to retract one stem cell paper

May 29, 2014

A Japanese stem cell scientist, under pressure over inconsistencies in her groundbreaking research, has agreed to retract one of the two papers published in the respected journal Nature, reports said Thursd ...

Recommended for you

YEATS protein potential therapeutic target for cancer

2 hours ago

Federal Express and UPS are no match for the human body when it comes to distribution. There exists in cancer biology an impressive packaging and delivery system that influences whether your body will develop cancer or not.

Precise and programmable biological circuits

3 hours ago

A team led by ETH professor Yaakov Benenson has developed several new components for biological circuits. These components are key building blocks for constructing precisely functioning and programmable bio-computers.

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

axemaster
not rated yet Aug 27, 2014
What is the deal with stem cell research and research fraud? Perhaps it's just being sensationalized, but it seems like the field is just wracked with corrupt practices.